ÂÜÀòÂÒÂ×

Debaleena Basu, Ph.D., is a Senior Scientist at Amgen since June 2021, specializing in small molecule drug development using biophysical techniques. Previous experience includes roles as a Senior Scientist at Bristol Myers Squibb and as a Scientist at Celgene, where Debaleena led binding characterization efforts for early discovery biologics, performed experiments using Biacore T200, and supported protein purification. Additional experience encompasses a position as Scientist IV at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on antibody lead optimization. Academic training includes a Ph.D. in Molecular Biology from Rutgers University, where research involved Shiga Toxins, as well as other educational qualifications in Botany/Plant Biology and Microbiology.